Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Main objective To assess the effects of policies that regulate drug promotion on drug utilization, coverage or access, healthcare utilization, patient outcomes, adverse events and costs. Secondary objective(s) To assess whether the effects of policies that regulate drug promotion to patients/consumers, healthcare professionals, regulators and third-party payers differ according to drug class, clinical indication, target groups and country (high-, middle- or low-income countries).
| Original language | English |
|---|---|
| Article number | CD013780 |
| Number of pages | 16 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2020 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 10 Nov 2020 |
Bibliographical note
Funding Information:We acknowledge the help and support of Cochrane Effective Practice and Organisation of Care (EPOC). We would also like to thank the following editors and peer referees who provided comments to improve the protocol: Simon Lewin (editor), Joel Lexchin, Svetlana Beilfuss; Elizabeth Paulsen, for continuous support; Marit Johansen for advice concerning the search strategy; and the Cochrane Copy Edit Support team for copy-editing the protocol. The Norwegian Satellite of the Effective Practice and Organisation of Care (EPOC) Group receives funding from the Norwegian Agency for Development Co-operation (Norad), via the Norwegian Institute of Public Health to support review authors in the production of their reviews.
Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.